MDGL
Madrigal Pharmaceuticals Inc.
Latest News for MDGL
Madrigal (($MDGL)) has held its Q1 earnings call. Read on for the main highlights of the call. Madrigal’s latest earnings call struck a confident t......
In a report released today, Srikripa Devarakonda from Truist Financial maintained a Buy rating on Madrigal Pharmaceuticals, with a price target of ......
In a report released today, Eliana Merle from Barclays maintained a Buy rating on Madrigal Pharmaceuticals, with a price target of $964.00. Accordi......
Madrigal (($MDGL)) has held its Q1 earnings call. Read on for the main highlights of the call. Madrigal’s latest earnings call struck an upbeat ton......
Madrigal (($MDGL)) has held its Q1 earnings call. Read on for the main highlights of the call. Madrigal’s latest earnings call struck an upbeat ton......
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Teladoc (TDOC), Madrigal Pharmaceuticals (MDGL) and Pulmonx (LUNG......
The latest announcement is out from Madrigal Pharmaceuticals ( ($MDGL) ). On April 22, 2026, Madrigal Pharmaceuticals’ board of directors reclassif......
News data is sourced from MarketXLS API and updated regularly.
Showing 7 of 7 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MDGL | $524.28 | +1.4% | 330.93K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Madrigal Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW